pharma is the sole category represented across all 1 tracked stories. Damien Leonard is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention ImmuCell Corporation, all published on March 4, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about ImmuCell Corporation
pharma is the sole category represented across all 1 tracked stories. Damien Leonard is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention ImmuCell Corporation, all published on March 4, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering ImmuCell Corporation. Shared-story counts are live from our verified record — not editorial picks.
ImmuCell (ICCC) reported its unaudited financial results for the full year 2025, reflecting a period of manufacturing expansion and sustained demand for its FirstDefense product line. Concurrently, major investor Pinetree Capital Ltd. announced its own audited results and a new director appointment, signaling continued strategic oversight of its animal health portfolio.
ImmuCell Corporation is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.